Page 723 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 723

696          Part SIX  Systemic Immune Diseases


        medications at the onset of pancreatitis, and most patients respond   organ involvement. The diagnosis is confirmed with an increased
        to steroid therapy. The clinical presentation and diagnosis of   α 1 -antitrypsin level in a 24-hour stool collection or with the
        pancreatitis is similar in patients with and without SLE. Specific   presence of IV-administered labeled human albumin in the stool.
        findings  in  SLE  include leukopenia, thrombocytopenia,  and   A recent review of 112 cases reported an Asian predominance
        anemia. Inflammation and necrosis are common on biopsy; there   (65%) and clinical features of edema (805), ascites (38%), pleural
        is a single report of pancreatic vasculitis. Mortality rates are   effusion (38%), pericardial effusion (21%), and hypocomple-
        reported from 18–27%; poor outcome is associated with increased   mentemia (79%). Approximately half the patients experienced
        systemic SLE activity (particularly, low complement and   diarrhea; intestinal histology revealed a range of findings,
        thrombocytopenia).                                     including lymphangiectasis, edematous villi, inflammatory
                                                               infiltrate, vasculitis, and mucosal atrophy. Biopsy results suggest
        Liver                                                  a role of TNF-α, IFN-γ, and IL-6 in the increased vascular and
        The term “lupoid hepatitis” was coined in the 1950s to describe   enterocyte permeability in PLE.
        cases of young women with chronic active hepatitis characterized
        by a lymphoplasmacytic infiltrate on biopsy, hypergammaglobu-  Pulmonary Involvement
        linemia, and a positive LE cell test in the blood.  With the   Lupus affects the lungs in diverse ways involving the pleura, lung
        development of ANA testing, it became apparent that “lupoid”   parenchyma, and blood vessels. The most frequent and important
        and “chronic active hepatitis” were indistinguishable in terms   complicating feature is infection.
        of clinical presentation, pathology, and response to treatment,
        and the term “autoimmune hepatitis” (AIH; Chapter 76) was   Pleuritis
                      54
        endorsed in 1993.  Importantly, only 10% of AIH meet criteria   Pleuritis  is  the  most  common  pulmonary manifestation
                                                                                                55
        for SLE, and 2.4–4.7% of SLE patients have noninfectious hepatitis   of SLE, reported in 40–56% of patients.  Pleural involvement
                       51
        attributed  to  SLE.   Analysis  of  SLE  liver  pathology  from  52   in up to 93% of lupus patients at autopsy suggests that
        autopsies in Japan revealed a variety of findings, including   much pleuritis may be asymptomatic. Clinically, patients note
        congestion (40/52), fatty liver (38/52), arteritis (11/52), cholestasis   typical pleuritic pain. On physical examination, the most frequent
        (9/52), and a few cases each of chronic persistent hepatitis, nodular   abnormality is tachypnea; a pleural friction rub is present in
        regenerative hyperplasia, hemangioma, and cholangiolitis. Cir-  some cases, and pleural effusions occur in more severe cases.
        rhosis is an extremely rare complication of liver involvement in   Pleural fluid is usually exudative with normal glucose and pH
        SLE. The distinction between subclinical liver inflammation   and elevated protein levels. The leukocyte count can range
        related to SLE (lupus hepatitis [LH]) and  AIH is important   from several hundred to 20 000 cells/µL; both a lymphocytic
        because therapy and prognosis are different.  Whereas LH is   and neutrophilic predominance are reported. When performed,
        associated with mild enzyme abnormalities, AIH is a progressive   immunological testing on pleural fluid may show reduced
        disease frequently leading to hepatic failure. Both conditions   complement levels and the presence of ANA, anti-DNA antibodies,
        share a predilection for young women, and both demonstrate   and LE cells.  Although these tests are commonly obtained,
        features of autoimmunity, including hypergammaglobulinemia,   these results are neither sensitive nor specific to diagnose
        arthralgias, and serum autoantibodies. Histologically, biopsies   lupus pleuritis.
        of LH reveal lobular and periportal lymphocytic infiltrates, in
        contrast to the periportal and piecemeal necrosis with dense   Lupus Pneumonitis
        lymphocytic infiltrates seen in AIH with progression to panlobular   Lupus pneumonitis occurs in up to 10% of patients. Patients
        or multilobular necrosis and cirrhosis. Serologically, antiribosomal   present with dyspnea, cough, mild pleuritic chest pain, and fever.
        P antibodies have been associated with liver disease in LH, whereas   Pulmonary infiltrates are present on plain radiograph or CT.
        AIH is associated with antibodies to liver and kidney microsomes.   This presentation must be distinguished from an infectious
        Antismooth-muscle antibodies are observed in 60–80% of patients   etiology. Histological examination of affected lung tissue shows
        with AIH, compared with 30% of patients with LH. Although   alveolar edema and hemorrhage with hyaline membrane forma-
        both have a favorable response to steroids, AIH usually requires   tion; immunofluorescent staining reveals immune complex
        additional immunosuppressive agents. 54                deposition.
           Distinguishing LH from hepatitis C (HCV) can be difficult.
        Up to 30% of patients chronically infected with HCV have low   Pulmonary Hemorrhage
        titers of ANA and other autoantibodies (anti-DNA, anticardiolipin   Pulmonary hemorrhage is a rare but potentially fatal complication
        antibodies, and rheumatoid factor). They can also have cryo-  of SLE. Symptoms include shortness of breath and hemoptysis
        globulins and associated cryoglobulinemic vasculitis. It is necessary   accompanied by a fall in hemoglobin, usually occurring in the
        to confirm a positive enzyme-linked immunosorbent assay   context of multiorgan involvement from SLE. Imaging may show
        (ELISA) for HCV with polymerase chain reaction (PCR) in   patchy infiltrates. Pulmonary function testing is marked by an
        patients presenting with arthritis, cutaneous vasculitis, and a   increased diffusion capacity (DL CO ) secondary to the presence
        positive ANA, as SLE patients may have false-positive serological   of alveolar blood, whereas arterial O 2  saturation is decreased.
        tests for HCV.                                         Histopathology  shows  bland  intraalveolar  hemorrhage  and
                                                               hemosiderin-laden macrophages, although microangiitis with
        Protein-Losing Enteropathy (PLE)                       an inflammatory infiltrate and necrosis of the alveolar septa can
        Profound hypoalbuminemia in the absence of severe nephrotic   occur. As hemorrhage into the lung may be secondary to throm-
        syndrome, liver disease, or constrictive pericarditis should trigger   botic thrombocytopenia, infections, or pulmonary hypertension,
        concern for PLE. Clinically significant PLE is uncommon in   demonstration of an inflammatory process in the pulmonary
        SLE, with reported prevalence rates of 1–8%; it can present   vessels or tissue is helpful to establish a diagnosis of primary
        individually or in the context of severe disease activity with other   pulmonary hemorrhage.
   718   719   720   721   722   723   724   725   726   727   728